IFNG and breast cancer: CHI3L1, as a protein involved in immune suppression in breast cancer, is directly correlated with the downregulation of IFN-γ expression in tumor-bearing mice, suggesting that CHI3L1 may participate in inducing pre-Th2-type responses, thereby reducing the production of Th1-type cytokines [35].